One Platform.
Multiple Applications.

Therapists face overwhelming caseloads, rising demand, and limited capacity. The WHO reports that 1 in 4 people will experience a mental-health disorder, yet waiting times for therapy can exceed 12 weeks in many European countries. This leads to delayed care and poor treatment adherence.

SwissDTx empowers psychotherapists to deliver blended care — combining in-person sessions with digital exercises, screeners, and psychoeducative content. The care cockpit allows efficient planning, monitoring, and secure communication with patients between sessions.

Hospitals face increasing patient volumes, short rehabilitation timeframes, and fragmented follow-up care. Post-discharge, over 40 % of patients report reduced adherence to prescribed programs (OECD 2023).

SwissDTx provides hospitals with a secure care cockpit and connected patient app for hybrid in- and outpatient pathways. Therapists assign digital exercises, psychoeducation, and assessments, ensuring continuous engagement and measurable outcomes.

Health insurers face rapidly rising costs caused by chronic diseases, mental-health disorders, and treatment dropouts. In Switzerland, non-communicable diseases account for over 80 % of healthcare expenditure (FOPH, 2024), while treatment adherence across chronic conditions averages only 50 % (WHO). Preventive measures often fail due to low engagement and lack of continuous monitoring.

SwissDTx enables insurers to implement blended-care programs that support prevention, chronic-disease management, and rehabilitation — seamlessly connecting insured members with healthcare professionals via the patient app and care cockpit. These digital pathways combine behavioral interventions, medical guidance, and structured self-management, generating anonymized outcome data for cost-benefit analysis.

Work-related stress is the leading cause of absenteeism in Europe, accounting for € 240 billion in annual costs (EU-OSHA 2023). Traditional corporate wellness initiatives lack personalization and measurable impact.

SwissDTx enables HR and health managers to deliver structured digital wellbeing programs combining psycho-education, stress management, and interactive self-reflection. Employees access modules anytime, supported by professionals if needed.

Medication adherence remains a critical issue: WHO estimates 50 % of patients with chronic illnesses do not take medication as prescribed. Traditional pharma follow-ups rarely offer behavioral support.

SwissDTx serves as a customizable companion app for pharmaceutical partners, providing digital coaching, reminders, and behavioral interventions supporting therapy adherence.

During crises or humanitarian missions, timely mental-health assessment and triage are crucial but often unavailable. WHO reports that over 80 % of crisis-affected populations lack structured psychosocial support.

SwissDTx provides multilingual self-assessment tools, psychoeducative content, and guided interventions accessible via smartphone — even in remote settings.

Traditional clinical trials face high dropout rates and logistical barriers. Decentralized Clinical Trials (DCTs) can reduce costs by 30 % but require reliable digital infrastructure (McKinsey 2024).

SwissDTx offers a secure, intervention-agnostic platform for running decentralized or hybrid trials. Researchers distribute screeners, collect longitudinal data, and maintain participant engagement through digital interventions.